Ten serwis zostanie wyłączony 2025-02-11.
Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na https://bibliotekanauki.pl
Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 9

Liczba wyników na stronie
first rewind previous Strona / 1 next fast forward last
Wyniki wyszukiwania
help Sortuj według:

help Ogranicz wyniki do:
first rewind previous Strona / 1 next fast forward last
|
|
tom 51
|
nr 1
EN
Three-day-old 105 Ross race female broiler chicks were used. The chickens were divided into 5 groups comprising 1 control and 4 experimental groups. Animals in the control group (group 1) were provided with normal drinking water, whereas the experimental groups, namely, group 2, group 3, group 4 and group 5 were administered with tilmicosin at doses of 20 ppm, 40 ppm, 80 ppm and 160 ppm (approximately, 5 mg/kg/b.w./d, 10 mg/kg/b.w./d, 20 mg/kg/b.w./d, and 40 mg/kg/b.w./d), respectively, via drinking water for a period of 3 d. Seven animals were euthanized from each group, on the 1st d (first period), 4th d (second period) and 7th d (third period) of the experiment for the assessment of blood malondialdehyde (MDA) levels and catalase (CAT) activity. Statistically significant differences in comparison with the control group were observed in plasma MDA levels of all experimental groups in the first period, groups 2 and 5 in the second period, and group 4 in the third period. With regards to CAT activity, a statistically significant decrease was found in all experimental groups only in the first period.
|
2008
|
tom 17
|
nr 2
189-197
EN
The aim of this study was to determine the clinical, hematological, biochemical and pathological findings, and to evaluate the efficiency of n-acetylcysteine (NAC) in experimentally induced aflatoxicosis in rabbits. Our study divided 42 rabbits into 6 groups. The groups received the following treatment: Group 1: control group without treatment, Group 2: aflatoxin (AF) (0.4 mg/kg body weight (bw)), Group 3: AF (0.4 mg/kg bw) plus NAC (250 mg/kg bw), Group 4: AF (0.4 mg/kg bw) plus NAC (500 mg/kg bw), Group 5: NAC (250 mg/kg bw), Group 6: NAC (500 mg/kg bw). N-acetylcysteine was administered intramuscularly on day 1 following the administration of AF for 5 days. At the beginning of the study and on days 1, 4 and 7 following the administration of AF, blood samples were collected for haematological and biochemical analysis. Necropsy and histopathological examination were performed. Clinical signs were observed starting from day 1 following the administration of AF. The signs of toxicosis included decreased feed and water consumption, dullness, dehydration, emaciation and convulsion. Four rabbits died in Group 2 and 2 rabbits died in Groups 3 and 4 treated with NAC. During the study, white blood cell (WBC) counts, mean platelet volume (MPV), mean corpuscular volume (MCV) and red blood cell distribution width (RDW) values, serum urea levels and aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and gamma glutamyl transpeptidase (GGT) activities increased whereas red blood cell (RBC) and platelet counts, hemoglobin (Hgb) and hematocrit (Hct) values, total protein, total cholesterol, triglyceride and glucose levels decreased for Group 2 given only AF compared with controls. These parameters approximated to control levels for Groups 3 and 4 after the treatment with NAC. Histopathological examination showed that the main affected organ was liver. Lipid degeneration, destruction and fibrosis in the liver were detected for Group 2. Histopathological changes in the liver were observed to be less severe for Groups 3 and 4. The study demonstrated that administration of NAC might be useful for the treatment of aflatoxicosis in rabbits.
EN
Twenty-eight mix-breed male dogs of approximately 3 years of age and with similar body weights were used in the study. Four groups, each including 7 animals, were established. The animals included in the first, second, third, and fourth groups were administered formulations A, B, C, and D, respectively, containing 200 mg sulfadoxine and 40 mg trimethoprim per millilitre, at a dose of 25 mg/kg body weight sulfadoxine by intramuscular route at the same site of the body. Subsequently, blood samples were collected at 0.083, 0.25, 0.50, 1.0, 1.5, 2.0, 4.0, 6.0, 12 and 24 hours. The levels of sulfadoxine-trimethoprim in the plasma samples were measured by means of a HPLC device. Pharmacokinetic calculations were performed in compliance with the two-compartment open model. According to statistical analyses, amongst the parameters evaluated, significant differences were determined to exist between the groups only with respect to the mathematical coefficients (A₂*), hybrid rate constant for terminal elimination phase (β), half life at α phase (t½α), half life at β phase (t½β) and mean residence time (MRT) values for sulfadoxine, and with respect to the A₁*, first order absorption rate constant (kₐ), β and MRT values for trimethoprim (p < 0.05).
first rewind previous Strona / 1 next fast forward last
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.